{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:44:23Z","timestamp":1788669863209,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China Grants","doi-asserted-by":"crossref","award":["81671618, 81871302"],"award-info":[{"award-number":["81671618, 81871302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the CAMS Initiative for Innovative Medicine","award":["2017-I2M-3-001, 2017-I2M-B&R-01"],"award-info":[{"award-number":["2017-I2M-3-001, 2017-I2M-B&R-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10067-020-05291-1","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T15:19:18Z","timestamp":1594999158000},"page":"819-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Assessment of diagnostic utility, clinical phenotypic associations, and prognostic significance of anti-NXP2 autoantibody in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Liubing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"5291_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project Consortium tER, the Juvenile Dermatomyositis Cohort Biomarker S, Repository (2017) 2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheum 69:2271\u20132282. https:\/\/doi.org\/10.1002\/art.40320","journal-title":"Arthritis Rheum"},{"key":"5291_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280:8\u201323. https:\/\/doi.org\/10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"5291_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14:290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"key":"5291_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Szollosi L, Danko K (2014) Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 13:1211\u20131219. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.011","journal-title":"Autoimmun Rev"},{"key":"5291_CR5","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/acr.23210","volume":"69","author":"A Rogers","year":"2017","unstructured":"Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF (2017) Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients. Arthritis Care Res 69:1909\u20131914. https:\/\/doi.org\/10.1002\/acr.23210","journal-title":"Arthritis Care Res"},{"key":"5291_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/acr.23188","volume":"69","author":"J Albayda","year":"2017","unstructured":"Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, Danoff SK, Johnson C, Christopher-Stine L, Mammen AL (2017) Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res 69:1771\u20131776. https:\/\/doi.org\/10.1002\/acr.23188","journal-title":"Arthritis Care Res"},{"key":"5291_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407. https:\/\/doi.org\/10.1056\/NEJM197502202920807","journal-title":"N Engl J Med"},{"key":"5291_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"5291_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626\u2013636. https:\/\/doi.org\/10.1067\/mjd.2002.120621","journal-title":"J Am Acad Dermatol"},{"key":"5291_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337\u2013345. https:\/\/doi.org\/10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord"},{"key":"5291_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project consortium TEr, The Juvenile Dermatomyositis Cohort Biomarker S, Repository (2017) 2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"5291_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705\u2013713. https:\/\/doi.org\/10.1002\/ana.410380504","journal-title":"Ann Neurol"},{"key":"5291_CR13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474. https:\/\/doi.org\/10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"5291_CR14","doi-asserted-by":"publisher","first-page":"2927061","DOI":"10.1155\/2019\/2927061","volume":"2019","author":"L Ye","year":"2019","unstructured":"Ye L, Zuo Y, Yang H, Li W, Peng Q, Lu X, Wang G, Shu X (2019) Specific autoantibodies and clinical phenotypes correlate with the aberrant expression of immune-related microRNAs in dermatomyositis. J Immunol Res 2019:2927061\u20132927012. https:\/\/doi.org\/10.1155\/2019\/2927061","journal-title":"J Immunol Res"},{"key":"5291_CR15","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","volume":"38","author":"S Li","year":"2019","unstructured":"Li S, Ge Y, Yang H, Wang T, Zheng X, Peng Q, Lu X, Wang G (2019) The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Clin Rheumatol 38:2171\u20132179. https:\/\/doi.org\/10.1007\/s10067-019-04503-7","journal-title":"Clin Rheumatol"},{"key":"5291_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2018.12.040","volume":"397","author":"L Li","year":"2019","unstructured":"Li L, Wang H, Wang Q, Wu C, Liu C, Zhang Y, Cheng L, Zeng X, Zhang F, Li Y (2019) Myositis-specific autoantibodies in dermatomyositis\/polymyositis with interstitial lung disease. J Neurol Sci 397:123\u2013128. https:\/\/doi.org\/10.1016\/j.jns.2018.12.040","journal-title":"J Neurol Sci"},{"key":"5291_CR17","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s10067-018-4216-x","volume":"37","author":"L Wang","year":"2018","unstructured":"Wang L, Huang L, Yang Y, Chen H, Liu Y, Liu K, Liu M, Xiao Y, Luo H, Zuo X, Li Y, Xiao X, Zhang H (2018) Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay. Clin Rheumatol 37:2731\u20132739. https:\/\/doi.org\/10.1007\/s10067-018-4216-x","journal-title":"Clin Rheumatol"},{"key":"5291_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/art.40491","volume":"70","author":"H Yang","year":"2018","unstructured":"Yang H, Lu X, Peng Q, Jiang W, Shi J, Zhang Y, Chen H, Wang G (2018) Differential clinical associations of anti-nuclear matrix protein 2 autoantibodies in patients with idiopathic inflammatory myopathies. Arthritis Rheum 70:1288\u20131297. https:\/\/doi.org\/10.1002\/art.40491","journal-title":"Arthritis Rheum"},{"key":"5291_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14397595.2018.1452353","volume":"29","author":"M Ueki","year":"2019","unstructured":"Ueki M, Kobayashi I, Takezaki S, Tozawa Y, Okura Y, Yamada M, Kuwana M, Ariga T (2019) Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Mod Rheumatol 29:351\u2013356. https:\/\/doi.org\/10.1080\/14397595.2018.1452353","journal-title":"Mod Rheumatol"},{"key":"5291_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/rheumatology\/kex516","volume":"57","author":"J Aouizerate","year":"2018","unstructured":"Aouizerate J, De Antonio M, Bader-Meunier B, Barnerias C, Bodemer C, Isapof A, Quartier P, Melki I, Charuel JL, Bassez G, Desguerre I, Gherardi RK, Authier FJ, Gitiaux C (2018) Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis. Rheumatology (Oxford) 57:873\u2013879. https:\/\/doi.org\/10.1093\/rheumatology\/kex516","journal-title":"Rheumatology (Oxford)"},{"key":"5291_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/jdv.14759","volume":"32","author":"M Best","year":"2018","unstructured":"Best M, Jachiet M, Molinari N, Manna F, Girard C, Pallure V, Cosnes A, Lipsker D, Hubiche T, Schmutz JL, Le Corre Y, Cordel N, Dandurand M, Dereure O, Guillot B, Du-Thanh A, Bulai Livideanu C, Chasset F, Bouaziz JD, Frances C, Bengoufa D, Vincent T, Bessis D, Study Group of Systemic Diseases in D (2018) Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients. J Eur Acad Dermatol Venereol 32:1164\u20131172. https:\/\/doi.org\/10.1111\/jdv.14759","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5291_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19:259. https:\/\/doi.org\/10.1186\/s13075-017-1469-8","journal-title":"Arthritis Res Ther"},{"key":"5291_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G, Betteridge ZE, Almeida B, Gunawardena H, Thomson W, Beresford MW, Midgley A, Muntoni F, Wedderburn LR, McHugh NJ (2017) Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun 84:55\u201364. https:\/\/doi.org\/10.1016\/j.jaut.2017.06.007","journal-title":"J Autoimmun"},{"key":"5291_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00403-016-1704-1","volume":"309","author":"G Merlo","year":"2017","unstructured":"Merlo G, Clapasson A, Cozzani E, Sanna L, Pesce G, Bagnasco M, Burlando M, Parodi A (2017) Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Arch Dermatol Res 309:87\u201395. https:\/\/doi.org\/10.1007\/s00403-016-1704-1","journal-title":"Arch Dermatol Res"},{"key":"5291_CR25","first-page":"303","volume":"35","author":"M Fredi","year":"2017","unstructured":"Fredi M, Bartoli F, Cavazzana I, Ceribelli A, Carabellese N, Tincani A, Satoh M, Franceschini F (2017) Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options. Clin Exp Rheumatol 35:303\u2013308","journal-title":"Clin Exp Rheumatol"},{"key":"5291_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10067-016-3453-0","volume":"36","author":"A Ceribelli","year":"2017","unstructured":"Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C (2017) Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Clin Rheumatol 36:469\u2013475. https:\/\/doi.org\/10.1007\/s10067-016-3453-0","journal-title":"Clin Rheumatol"},{"key":"5291_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000172","volume":"2","author":"AL Mammen","year":"2015","unstructured":"Mammen AL, Casciola-Rosen L, Christopher-Stine L, Lloyd TE, Wagner KR (2015) Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease. Neurol Neuroimmunol Neuroinflamm 2:e172. https:\/\/doi.org\/10.1212\/NXI.0000000000000172","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5291_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/md.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourre-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senecal JL (2014) Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore) 93:318\u2013332. https:\/\/doi.org\/10.1097\/md.0000000000000222","journal-title":"Medicine (Baltimore)"},{"key":"5291_CR29","first-page":"891","volume":"32","author":"A Ceribelli","year":"2014","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, Chan JY, Chan EK, Satoh M, Franceschini F (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol 32:891\u2013897","journal-title":"Clin Exp Rheumatol"},{"key":"5291_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jmii.2014.05.012","volume":"49","author":"HH Yu","year":"2016","unstructured":"Yu HH, Chang HM, Chiu CJ, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL (2016) Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis. J Microbiol Immunol Infect 49:264\u2013270. https:\/\/doi.org\/10.1016\/j.jmii.2014.05.012","journal-title":"J Microbiol Immunol Infect"},{"key":"5291_CR31","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","volume":"53","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, McHugh NJ, Juvenile Dermatomyositis Research G (2014) Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 53:2204\u20132208. https:\/\/doi.org\/10.1093\/rheumatology\/keu259","journal-title":"Rheumatology (Oxford)"},{"key":"5291_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"A Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L, Fiorentino D (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150:724\u2013729. https:\/\/doi.org\/10.1001\/jamadermatol.2013.10416","journal-title":"JAMA Dermatol"},{"key":"5291_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3109\/14397595.2014.896494","volume":"24","author":"EH Kang","year":"2014","unstructured":"Kang EH, Kuwana M, Okazaki Y, Lee EY, Lee YJ, Lee EB, Song YW (2014) Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients. Mod Rheumatol 24:945\u2013948. https:\/\/doi.org\/10.3109\/14397595.2014.896494","journal-title":"Mod Rheumatol"},{"key":"5291_CR34","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, Rosen A, Casciola-Rosen L (2013) Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma. Arthritis Rheum 65:2954\u20132962. https:\/\/doi.org\/10.1002\/art.38093","journal-title":"Arthritis Rheum"},{"key":"5291_CR35","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M, Tincani A, Ross SJ, Chan JY, Pauley BA, Chan EK, Satoh M (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14:R97. https:\/\/doi.org\/10.1186\/ar3822","journal-title":"Arthritis Res Ther"},{"key":"5291_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","volume":"51","author":"A Ishikawa","year":"2012","unstructured":"Ishikawa A, Muro Y, Sugiura K, Akiyama M (2012) Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology (Oxford) 51:1181\u20131187. https:\/\/doi.org\/10.1093\/rheumatology\/kes033","journal-title":"Rheumatology (Oxford)"},{"key":"5291_CR37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, Inokoshi Y, Kawai K, Kanekura T, Habuchi M, Igarashi A, Sogame R, Hashimoto T, Koga T, Nishino A, Ishiguro N, Sugimoto N, Aoki R, Ando N, Abe T, Kanda T, Kuwana M, Takehara K, Fujimoto M (2012) Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71:710\u2013713. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200697","journal-title":"Ann Rheum Dis"},{"key":"5291_CR38","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group UK, Ireland (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814. https:\/\/doi.org\/10.1002\/art.24547","journal-title":"Arthritis Rheum"},{"key":"5291_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","volume":"16","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Uruha A, Suzuki N, Nishino I (2017) Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology. Autoimmun Rev 16:693\u2013700. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.003","journal-title":"Autoimmun Rev"},{"key":"5291_CR40","first-page":"652","volume":"40","author":"CV Oddis","year":"1997","unstructured":"Oddis CV, Fertig N, Goel A, Espada G, Gregorian MC, Cocco JAM, Londino AV (1997) Clinical and serological characterization of the anti-MJ antibody in childhood myositis. Arthritis Rheum 40:652\u2013652","journal-title":"Arthritis Rheum"},{"key":"5291_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clim.2018.11.008","volume":"198","author":"L Zhong","year":"2019","unstructured":"Zhong L, Yu Z, Song H (2019) Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: a meta-analysis of 20 cohorts. Clin Immunol 198:11\u201318. https:\/\/doi.org\/10.1016\/j.clim.2018.11.008","journal-title":"Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05291-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:54:11Z","timestamp":1626479651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05291-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5291"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05291-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}